- Stocks
- Real Estate
- NYSE: NHI

Price (delayed)

$65.14

Market cap

$2.99B

P/E Ratio

18.35

Dividend/share

$4.41

EPS

$3.55

Enterprise value

$4.4B

NHI's equity is up by 3.8% YoY and by 2.6% from the previous quarter

NHI's P/E is 13% more than its last 4 quarters average of 16.3 but 2.4% less than its 5-year quarterly average of 18.8

National Health Investors's EPS has decreased by 16% YoY and by 14% QoQ

The net income is down by 14% year-on-year and by 14% since the previous quarter

What are the main financial stats of NHI

Market
Valuations
Earnings

Shares outstanding

45.85M

Market cap

$2.99B

Enterprise value

$4.4B

Price to earnings (P/E)

18.35

Price to book (P/B)

1.9

Price to sales (P/S)

8.93

EV/EBIT

20.83

EV/EBITDA

14.93

EV/Sales

13.3

Revenue

$330.6M

EBIT

$211.15M

EBITDA

$294.66M

Free cash flow

$197.2M

Per share
Balance sheet
Liquidity

EPS

$3.55

Free cash flow per share

$4.35

Book value per share

$34.35

Revenue per share

$7.3

TBVPS

$70.26

Total assets

$3.18B

Total liabilities

$1.62B

Debt

$1.52B

Equity

$1.55B

Working capital

N/A

Debt to equity

0.98

Current ratio

N/A

Quick ratio

N/A

Net debt/EBITDA

4.79

Margins
Efficiency
Dividend

EBITDA margin

89.1%

Gross margin

100%

Net margin

48.2%

Operating margin

66.5%

Return on assets

5.1%

Return on equity

10.5%

Return on invested capital

4.6%

Return on capital employed

N/A

Return on sales

63.9%

Dividend yield

6.77%

DPS

$4.41

Payout ratio

124.3%

How has the National Health Investors stock price performed over time

Intraday

-0.73%

1 week

-2.06%

1 month

-2.63%

1 year

2.71%

YTD

-5.83%

QTD

-9.88%

How have National Health Investors's revenue and profit performed over time

Revenue

$330.6M

Gross profit

$330.6M

Operating income

$219.9M

Net income

$159.44M

Gross margin

100%

Net margin

48.2%

The net margin has declined by 16% year-on-year and by 13% since the previous quarter

The net income is down by 14% year-on-year and by 14% since the previous quarter

The operating margin has contracted by 4.2% YoY

The operating income is down by 2.5% year-on-year and by 2.2% since the previous quarter

What is National Health Investors's growth rate over time

What is National Health Investors stock price valuation

P/E

18.35

P/B

1.9

P/S

8.93

EV/EBIT

20.83

EV/EBITDA

14.93

EV/Sales

13.3

National Health Investors's EPS has decreased by 16% YoY and by 14% QoQ

NHI's P/E is 13% more than its last 4 quarters average of 16.3 but 2.4% less than its 5-year quarterly average of 18.8

NHI's price to book (P/B) is 14% less than its 5-year quarterly average of 2.2

NHI's equity is up by 3.8% YoY and by 2.6% from the previous quarter

The stock's P/S is 16% less than its 5-year quarterly average of 10.6

How efficient is National Health Investors business performance

The ROE has contracted by 17% YoY and by 15% from the previous quarter

The return on assets has declined by 16% year-on-year and by 14% since the previous quarter

The ROIC has declined by 15% year-on-year and by 10% since the previous quarter

National Health Investors's return on sales has decreased by 14% YoY and by 11% QoQ

What is NHI's dividend history

DPS

$4.41

Dividend yield

6.77%

Payout ratio

124.3%

Recent dividends

How did National Health Investors financials performed over time

The total assets is 96% more than the total liabilities

The total liabilities has contracted by 2.4% YoY

The total assets has grown by 2% from the previous quarter

The debt to equity has contracted by 6% YoY

NHI's equity is up by 3.8% YoY and by 2.6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.